Atlas Trials

Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia

Clinical trial NCT00103571 · COMPLETED

Trial details

NCT number
NCT00103571
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2004-07-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.